Greg Guyer is an accomplished executive in the pharmaceutical and biotechnology industries, currently serving as Executive Vice President and Chief Technical Officer at BioMarin Pharmaceutical Inc. since May 2020. Previously, at Bristol-Myers Squibb from November 2015 to November 2019, Greg led global operations, managing multiple manufacturing sites and directing the development of biologics product processes. Greg’s extensive experience at Merck included roles as Senior Vice President for Operations and Global Quality, where significant advancements in biologics capabilities and quality systems were achieved. Greg holds a PhD in Analytical Chemistry from American University, an MBA in Marketing from Lehigh University, and a BS in Chemistry from the University of Georgia.
This person is not in any offices